Author

Mengfang Yang

Jiangsu University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Ling LiuiD· 1 shared Lingli Luo· 1 shared Weijun ReniD· 1 shared X W LiiD· 1 shared Yong Jiang· 1 shared Yuanyuan YaniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ling LiuORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Clonal morphology-guided combination therapies overcome heterogeneity-driven drug tolerance

X W Li, Ling Liu, Yuanyuan Yan, Mengfang Yang, Lingli Luo, Yong Jiang, Weijun Ren

This study identifies clonal morphology as a marker of tumor heterogeneity and shows that clone-selective drug combinations can overcome resistance by targeting distinct clonal populations.

bioRxiv · Feb 3, 2026 · PreprintCancer Biology